.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
Novartis
Mallinckrodt
Express Scripts
Colorcon
QuintilesIMS
Farmers Insurance
Johnson and Johnson
Dow

Generated: February 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Switzerland Patent: 1593/96

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpJADENU SPRINKLEdeferasiroxGRANULE;ORAL207968-001May 18, 2017RXYesNo➤ Sign Up➤ Sign UpYY
Novartis Pharms CorpJADENU SPRINKLEdeferasiroxGRANULE;ORAL207968-002May 18, 2017RXYesNo➤ Sign Up➤ Sign UpYY
Novartis Pharms CorpJADENU SPRINKLEdeferasiroxGRANULE;ORAL207968-003May 18, 2017RXYesYes➤ Sign Up➤ Sign UpYY
NovartisEXJADEdeferasiroxTABLET, FOR SUSPENSION;ORAL021882-001Nov 2, 2005ABRXYesNo➤ Sign Up➤ Sign UpYY
NovartisEXJADEdeferasiroxTABLET, FOR SUSPENSION;ORAL021882-002Nov 2, 2005ABRXYesNo➤ Sign Up➤ Sign UpYY
NovartisEXJADEdeferasiroxTABLET, FOR SUSPENSION;ORAL021882-003Nov 2, 2005ABRXYesYes➤ Sign Up➤ Sign UpYY
Novartis Pharms CorpJADENUdeferasiroxTABLET;ORAL206910-001Mar 30, 2015RXYesNo➤ Sign Up➤ Sign UpYY
Novartis Pharms CorpJADENUdeferasiroxTABLET;ORAL206910-002Mar 30, 2015RXYesNo➤ Sign Up➤ Sign UpYY
Novartis Pharms CorpJADENUdeferasiroxTABLET;ORAL206910-003Mar 30, 2015RXYesYes➤ Sign Up➤ Sign UpYY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist